Menu

非布司他价格多少一盒呢?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Inhibits uric acid production by inhibiting xanthine oxidase (XO). Allopurinol can inhibit the reduced form of XO, while febuxostat has a good inhibitory effect on both the reduced and oxidized forms, so the uric acid-lowering effect is more powerful and faster. The listing of febuxostat has been approved by many countries. So, how much does a box of febuxostat cost?

According to Medical Companion Travel, the price of febuxostat is not very high, and most patients can afford it. The price of a box of 80mg*30 tablets is about $200. Febuxostat produced by Zydus Pharmaceutical Factory in India has the same efficacy as the original drug, but the price is indeed much lower. However, due to exchange rate fluctuations, the price is different. For specific prices, please consult the regular overseas medical service company Medical Companion Travel.

Compared with the price of febuxostat in India, the price of the original drug in Japan is relatively high, about 1500$ per box.

In addition, the price of a box of febuxostat is around 200$, so patients have no financial pressure. Febuxostat does not affect the synthesis and metabolism of other purine pyrimidines, and has the effect of strongly reducing uric acid. It can exert high activity in a small dose and is relatively safe. It is completely effective and has good safety and tolerance for patients who are not suitable for allopurinol treatment. It is cheap but also highly safe. Febuxostat has become the first choice of professional rheumatology and immunology doctors. For a while, febuxostat has become the "miracle drug" that patients take seriously.

Some people think that febuxostat is an effective drug for the treatment of gout. In fact, gout is a group of metabolic diseases. Febuxostat only lowers blood uric acid and prevents gout attacks. However, the original drug recommended by doctors, allopurinol, has an allergic risk of about 1.5%. Severe cases may lead to fatal allergies, and there is also a 1.2% risk of liver damage. The advantages of febuxostat in these two aspects are obviously better than that of allopurinol, and patients have high hopes for febuxostat to replace allopurinol. However, patients should use it under the guidance of a doctor because there are risk factors for liver damage and cardiovascular disease.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。